medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2017, Number 2

<< Back

Rev Latin Infect Pediatr 2017; 30 (2)

Simultaneous acute rheumatic fever and septic arthritis by Streptococcus pyogenes in a preschool child

Santos HJE, Mercado UMC, Luévanos VA, Plascencia HA, Martínez APA, Guerrero BM, Oseguera ÁF

Language: Spanish
References: 14
Page: 80-84
PDF size: 294.88 Kb.


ABSTRACT

The WHO has estimated that approximately 500,000 people suffer annually from an acute attack of rheumatic fever (RF); two thirds of them will develop rheumatic heart disease. S. pyogenes is the causal bacteria of this disease. RF is secondary to an acute streptococcal infection; it is cataloged as an autoimmune disease characterized by kidney, heart and skin inflammation. The age of presentation associated with increased incidence is between five and 15 years; only about 5% of the cases occur in children under that age. We present a case of a 35-month-old patient with simultaneous acute RF and septic arthritis by S. pyogenes who developed myocarditis, tricuspid insufficiency and pericardial effusion.


REFERENCES

  1. Pickering LK, Baker CJ, Kimberlin DW. Red book. Enfermedades infecciosas en pediatría. 28.ª ed. Madrid: Editorial Médica Panamericana; 2011.

  2. Mandell GL, Bennett JE, Dolin R. Principles and practice of infectious diseases. 8.a ed. Editorial Elsevier; 2015. pp. 1955-1971.

  3. Steer A, Carapetis J. Fiebre reumática aguda y cardiopatía reumática en población indígena. Pediartr Clin N Am. 2010; 56: 1401-1419.

  4. Ros J. Fiebre reumática y artritis postestreptocócica. Protoc diagn ter pediatr. 2014; 1: 165-75.

  5. Carapetis JR, Steer AC, Mulholland EK et al. The global burden of group A streptococcal
diseases. Lancet Infect Dis. 2005; 5: 685-694.

  6. Rammelkamp CH Jr, Stolzer BL. The latent period before the onset of acute rheumatic fever. Yale J Biol Med. 1961; 34: 386-398.

  7. Sistema Nacional de Vigilancia Epidemiológica. Sistema Único de Información. Boletín epidemiológico. Secretaría de Salud. Número 37, volumen 33, semana 47.

  8. Excler JL, Kim JH. Accelerating the development of a group A streptococcus vaccine: an urgent public health need. Clin Exp Vaccine Res 2016; 5: 101-107.

  9. Gerber M, Baltimore R, Eaton C et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association on rheumatic fever. Journal of the American Heart Association. 2009; 119: 11.

  10. Santamaría H, Gaytán G, Quiñones RM, Gómez M. Fiebre reumática. ¿Es aún un problema en los niños? A propósito de un caso. Rev Mex Pediatr. 2006; 73 (3): 127-131.

  11. Siegel AC, Johnson EE, Stollerman GH. Controlled studies of streptococcal pharyngitis in a pediatric population. I. Factors related to the attack rate of rheumatic fever. N Engl J Med. 1961; 265: 559-566.

  12. Antón J. Fiebre reumática y artritis reactiva post-estreptocócica. Pediatr Integral. 2013; 17 (1): 47-56

  13. De Matos A, Feres MC, Duenhas TA, Sobreira G, Serrano CV, Tarasoutchi F. Asociación entre enfermedades inmunológicas y sus manifestaciones clínicas semejantes. Arq Bras Cardiol. 2012; 98 (2): e28-e31.

  14. New Zealand Guidelines for Rheumatic Fever. Diagnosis, management and secondary prevention of acute rheumatic fever and rheumatic heart disease: 2014 update.




2020     |     www.medigraphic.com